OncoTherapy Science, Inc.
TSE:4564.T
Overview | Financials
Company Name | OncoTherapy Science, Inc. |
Symbol | 4564.T |
Currency | JPY |
Price | 32 |
Market Cap | 8,692,606,368 |
Dividend Yield | 0% |
52-week-range | 15 - 64 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Junichi Shimada |
Website | https://www.oncotherapy.co.jp |
An error occurred while fetching data.
About OncoTherapy Science, Inc.
OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD